Ticagrelor Versus Cilostazol in Large-vessel Ischemic Stroke
Status:
RECRUITING
Trial end date:
2025-07-12
Target enrollment:
Participant gender:
Summary
Along with the current clinical trial, the efficacy and safety of 180 mg loading dose of ticagrelor administered within 24 hours of first-ever large-vessel ischemic stroke compared to 200 mg cilostazol were assessed through NIHSS, mRS, and possible adverse effects.